Native Bio-Lenticules Mediated Rapamycin Delivery for Corneal Immunomodulation and Tissue Repair Promotion
ACS Biomaterials Science & Engineering · 2025
DOI: 10.1021/acsbiomaterials.5c01309 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Zhanyu Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Aier Academy of Ophthalmology, Central South University, Changsha, Hunan 410000, P. R. China. Hauptthemen laut MEDLINE: Sirolimus, Cornea, Immunomodulation, Immunosuppressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Aier Eye Institute, AIER Eye Group.
Abstract (Originalsprache)
Corneal damage-related disorders, characterized by stromal opacity due to trauma, infection, or other etiologies, remain a major cause of visual impairment. Despite therapeutic advances, the scarcity of donor corneal grafts and the complexity of immune regulation continue to pose critical challenges. To address these limitations, we developed a novel immunomodulatory biomaterial composed of decellularized human stromal lenticules and rapamycin (RAPA) solubilized with deep eutectic solvents. Designed for interlamellar corneal implantation, this drug-loaded construct enables localized, sustained delivery of RAPA, exerting potent immunosuppressive and anti-inflammatory effects. In vitro, the RAPA-loaded lenticules maintained high transparency comparable to native human cornea and achieved controlled drug release for over 35 days. Additionally, the drug incorporation process enhanced both the biomechanical strength and the biocompatibility of the lenticules. Following interstromal transplantation into rabbit corneas, 1% RAPA-loaded grafts preserved corneal clarity for more than one month without triggering observable immune rejection. Histological evaluation confirmed the presence of neuronal markers within the grafts, indicating successful host-mediated nerve regeneration and a favorable balance between immune modulation and tissue repair. Collectively, these findings demonstrate that RAPA-loaded lenticules function as transparent, biomechanically robust, and immunosuppressive grafts with a strong potential for clinical translation in the treatment of corneal injuries and immune-mediated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aier Academy of Ophthalmology, Central South University, Changsha, Hunan 410000, P. R. China.
- Aier Eye Hospital, Jinan University, Guangzhou, Guangdong 510000, P. R. China.
- School of Medicine, Northwest University, Xi'an, Shaanxi 710000, P. R. China.
- Changsha Aier Eye Hospital, Aier Eye Institute, Changsha, Hunan 410004, P. R. China.
- Xi'an Aier Eye Hospital, Northwest University, Xi'an, Shaanxi 710000, P. R. China.
- Xi'an People's Hospital: Xi'an Fourth Hospital, Northwest University, Xi'an, Shaanxi 710000, P. R. China.
ORCID-Profile: Zhanyu Su, Zhuoyue Chen, Jiansu Chen
Förderung
- Natural Science Foundation of Hunan Province
- Aier Eye Institute
- AIER Eye Group
Zitieren
APA
Su, Z., Chen, Y., Zhou, Y., Cui, Z., Yang, J., Chen, Z., Chen, J., Gu, J., & Li, K. (2025). Native Bio-Lenticules Mediated Rapamycin Delivery for Corneal Immunomodulation and Tissue Repair Promotion. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01309
Vancouver
Su Z, Chen Y, Zhou Y, Cui Z, Yang J, Chen Z, et al. Native Bio-Lenticules Mediated Rapamycin Delivery for Corneal Immunomodulation and Tissue Repair Promotion. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c01309
BibTeX
@article{Su2025,
author = {Su, Zhanyu and Chen, Yuexi and Zhou, Yumeng and Cui, Zekai and Yang, Jie and Chen, Zhuoyue and Chen, Jiansu and Gu, Jianing and Li, Kangjun},
title = {Native Bio-Lenticules Mediated Rapamycin Delivery for Corneal Immunomodulation and Tissue Repair Promotion},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
doi = {10.1021/acsbiomaterials.5c01309}
}
EUVIMED